Amneal Pharmaceuticals LLC’s Increased Term Loan Facility
June 15, 2016
Cravath represented the syndication agent, JPMorgan Chase Bank, N.A., in connection with the arrangement of a $225 million increase to the existing term loan B facility for Amneal Pharmaceuticals LLC, a manufacturer and distributor of affordable medicines. The transaction closed on May 24, 2016.
The Cravath team included partner George E. Zobitz and associate David J. Benhamou on banking matters; associate Dmitry Zelik on tax matters; and partner Matthew Morreale on environmental matters. Ashley May and Brian B. Kennedy also worked on tax and executive compensation and benefits matters, respectively.
Related Practices & Industries
People
-
J.D., 1995, New York University School of Lawwith Honors, cum laude
-
B.A., 1991, Franklin & Marshall College
- New York
Education
Admitted In
- Photo
-
-
J.D., 1997, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Pennsylvania
-
B.A., 1990, University of Pennsylvania
-
B.A.S., 1990, University of Pennsylvania
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
August 06, 2025
JPMorgan Chase & Co.’s $4 Billion Registered Fixed‑to‑Floating Rate Subordinated Notes Offering
Cravath represented the underwriters in connection with the $4 billion registered fixed‑to‑floating rate subordinated notes offering of JPMorgan Chase & Co., a leading global financial services firm. The transaction closed on July 23, 2025.
Deals & Cases
May 06, 2025
JPMorgan Chase & Co.’s $6 Billion Registered Fixed‑to‑Floating Rate Notes Offering
Cravath represented the underwriters in connection with the $6 billion registered fixed‑to‑floating rate notes offering of JPMorgan Chase & Co., a leading global financial services firm. The transaction closed on April 22, 2025.
Deals & Cases
February 18, 2025
JPMorgan Chase & Co.’s $3 Billion Registered Offering of Depositary Shares
Cravath represented the underwriters in connection with the $3 billion registered offering of depositary shares representing preferred stock of JPMorgan Chase & Co., a leading global financial services firm and one of the largest banking institutions in the United States. The transaction closed on February 4, 2025.
Deals & Cases
February 07, 2025
JPMorgan Chase’s $8 Billion Registered Floating and Fixed-to-Floating Rate Notes Offering
Cravath represented the underwriters in connection with the $8 billion registered floating and fixed-to-floating rate notes offering of JPMorgan Chase & Co., a leading global financial services firm. The transaction closed on January 24, 2025.
